MedPath

Study on evaluation of reduction effect of test supplement on body fat -a randomized, double blind, placebo controlled, parallel group comparison study

Not Applicable
Conditions
Healthy subject
Registration Number
JPRN-UMIN000037062
Lead Sponsor
TTC Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
104
Inclusion Criteria

Not provided

Exclusion Criteria

1. Subjects who are currently under medical treatment, diet therapy or exercise therapy. 2. Subjects who are under treatment or have a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease, abnormal secretion disease of adrenocortical hormone) 3. Subjects with allergies to the test food in this study 4. Females who are known or suspected to be pregnant, breastfeeding or desire to become pregnant during the trial period. 5. Subjects who routinely use some medicine, health foods affecting body fat or lipid metabolism. 6. Subjects who currently are dieting. 7. Subjects who have participated in other clinical study within the past month prior. 8. Subjects who use some medicine, food containing lactic acid bacteria or polymethoxyflavone 3 days a week or more from half a year before the informed consent. 9. Subjects who are judges as unsuitable for the study based on the results of lifestyle questionnaire 10. Subjects who are judged as unsuitable for the study based on the results of clinical laboratory test or cardiopulmonary function. 11. Subjects who have diseases requiring continuous medication, or serious medical history who needed medication therapy 12. Subjects who always use laxative when defecation. 13. Subjects who have taken antibiotics within the past month 14. Subjects who are judged as unsuitable for the study based on the results of clinical laboratory test or physical examination. 15. Subjects who are planning to travel abroad during the study period, or who are planning of long term domestic trip for more than one week in study period. 16. Subjects who are judged as unsuitable for the study by the investigator for other reason

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Abdominal visceral fat area
Secondary Outcome Measures
NameTimeMethod
Abdominal total fat area, abdominal subcutaneous fat area, body weight, BMI, waist circumference, hip circumference, ratio of waist and hip circumferences, subgroup analysis (BMI, abdominal visceral fat area, sex, defecation frequency)
© Copyright 2025. All Rights Reserved by MedPath